Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms

BACKGROUND: Identification of circulating tumor markers for clinical management in bronchopulmonary (BP) neuroendocrine tumors/neoplasms (NET/NEN) is of considerable clinical interest. Chromogranin A (CgA), a “universal” NET biomarker, is considered controversial as a circulating biomarker of BPNEN....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuroendocrinology
Autori principali: Matar, Somer, Malczewska, Anna, Oberg, Kjell, Bodei, Lisa, Aslanian, Harry, Lewczuk-Myślicka, Anna, Filosso, Pier Luigi, Suarez, Alejandro L., Kolasińska-Ćwikła, Agnieszka, Roffinella, Matteo, Kos-Kudła, Beata, Ćwikła, Jarosław B., Drozdov, Ignat A., Kidd, Mark, Modlin, Irvin M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7472424/
https://ncbi.nlm.nih.gov/pubmed/30995665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000500202
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi